VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $509,000 | +47.1% | 21,950 | +0.9% | 0.07% | +50.0% |
| Q1 2018 | $346,000 | -24.0% | 21,750 | -0.5% | 0.05% | -23.3% |
| Q4 2017 | $455,000 | +35.0% | 21,850 | -7.7% | 0.06% | +22.4% |
| Q3 2017 | $337,000 | +26.2% | 23,675 | +55.0% | 0.05% | +11.4% |
| Q2 2017 | $267,000 | +107.0% | 15,275 | +32.3% | 0.04% | +100.0% |
| Q1 2017 | $129,000 | -60.2% | 11,550 | -12.6% | 0.02% | -59.3% |
| Q3 2016 | $324,000 | – | 13,208 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |